General Information of the m6A Target Gene (ID: M6ATAR00334)
Target Name 72 kDa type IV collagenase (MMP2)
Synonyms
72 kDa gelatinase; Gelatinase A; Matrix metalloproteinase-2; MMP-2; TBE-1; CLG4A
    Click to Show/Hide
Gene Name MMP2
Chromosomal Location 16q12.2
Family peptidase M10A family
Function
Ubiquitinous metalloproteinase that is involved in diverse functions such as remodeling of the vasculature, angiogenesis, tissue repair, tumor invasion, inflammation, and atherosclerotic plaque rupture. As well as degrading extracellular matrix proteins, can also act on several nonmatrix proteins such as big endothelial 1 and beta-type CGRP promoting vasoconstriction. Also cleaves KISS at a Gly-|-Leu bond. Appears to have a role in myocardial cell death pathways. Contributes to myocardial oxidative stress by regulating the activity of GSK3beta. Cleaves GSK3beta in vitro. Involved in the formation of the fibrovascular tissues in association with MMP14.; PEX, the C-terminal non-catalytic fragment of MMP2, posseses anti-angiogenic and anti-tumor properties and inhibits cell migration and cell adhesion to FGF2 and vitronectin. Ligand for integrinv/beta3 on the surface of blood vessels.; [Isoform 2]: Mediates the proteolysis of CHUK/IKKA and initiates a primary innate immune response by inducing mitochondrial-nuclear stress signaling with activation of the pro-inflammatory NF-kappaB, NFAT and IRF transcriptional pathways.
    Click to Show/Hide
Gene ID 4313
Uniprot ID
MMP2_HUMAN
HGNC ID
HGNC:7166
Ensembl Gene ID
ENSG00000087245
KEGG ID
hsa:4313
Full List of m6A Methylation Regulator of This Target Gene and Corresponding Disease/Drug Response(s)
MMP2 can be regulated by the following regulator(s), and cause disease/drug response(s). You can browse detail information of regulator(s) or disease/drug response(s).
Browse Regulator
Browse Disease
Methyltransferase-like 3 (METTL3) [WRITER]
Representative RNA-seq result indicating the expression of this target gene regulated by METTL3
Cell Line LX2 cell line Homo sapiens
Treatment: shMETTL3 LX2 cells
Control: shLuc LX2 cells
GSE207909
Regulation
logFC: 7.46E-01
p-value: 1.39E-03
More Results Click to View More RNA-seq Results
Representative RIP-seq result supporting the interaction between MMP2 and the regulator
Cell Line MDA-MB-231 Homo sapiens
Regulation logFC: 1.08E+00 GSE60213
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [1]
Response Summary METTL3 is upregulated in human melanoma and plays a role in invasion/migration through MMP2. METTL3 overexpression promotes accumulation of 72 kDa type IV collagenase (MMP2) and N-cadherin in melanoma cells.
Target Regulation Up regulation
Responsed Disease Melanoma ICD-11: 2C30
Cell Process Cell invasion/migration
In-vitro Model 451Lu Cutaneous melanoma Homo sapiens CVCL_6357
A-375 Amelanotic melanoma Homo sapiens CVCL_0132
A375-MA2 Amelanotic melanoma Homo sapiens CVCL_X495
MeWo Cutaneous melanoma Homo sapiens CVCL_0445
SK-MEL-2 Melanoma Homo sapiens CVCL_0069
WM164 Cutaneous melanoma Homo sapiens CVCL_7928
WM3211 Acral lentiginous melanoma Homo sapiens CVCL_6797
WM3918 Melanoma Homo sapiens CVCL_C279
WM793 Melanoma Homo sapiens CVCL_8787
E3 ubiquitin-protein ligase Hakai (CBLL1) [WRITER]
In total 1 item(s) under this regulator
Experiment 1 Reporting the m6A Methylation Regulator of This Target Gene [2]
Response Summary CBLL1 was frequently upregulated in non-small lung cancer (NSCLC) tissues compared to the adjacent nontumor tissues. CBLL1 knockdown inhibited cell invasion via increased E-cadherin protein expression, and decreased expression of 72 kDa type IV collagenase (MMP2) and MMP9 in NSCLC cell lines.
Responsed Disease Non-small-cell lung carcinoma ICD-11: 2C25.Y
In-vitro Model A-549 Lung adenocarcinoma Homo sapiens CVCL_0023
NCI-H1299 Lung large cell carcinoma Homo sapiens CVCL_0060
SK-MES-1 Lung squamous cell carcinoma Homo sapiens CVCL_0630
Lung cancer [ICD-11: 2C25]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [2]
Response Summary CBLL1 was frequently upregulated in non-small lung cancer (NSCLC) tissues compared to the adjacent nontumor tissues. CBLL1 knockdown inhibited cell invasion via increased E-cadherin protein expression, and decreased expression of 72 kDa type IV collagenase (MMP2) and MMP9 in NSCLC cell lines.
Responsed Disease Non-small-cell lung carcinoma [ICD-11: 2C25.Y]
Target Regulator E3 ubiquitin-protein ligase Hakai (CBLL1) WRITER
In-vitro Model A-549 Lung adenocarcinoma Homo sapiens CVCL_0023
NCI-H1299 Lung large cell carcinoma Homo sapiens CVCL_0060
SK-MES-1 Lung squamous cell carcinoma Homo sapiens CVCL_0630
Melanoma [ICD-11: 2C30]
In total 1 item(s) under this disease
Experiment 1 Reporting the m6A-centered Disease Response [1]
Response Summary METTL3 is upregulated in human melanoma and plays a role in invasion/migration through MMP2. METTL3 overexpression promotes accumulation of 72 kDa type IV collagenase (MMP2) and N-cadherin in melanoma cells.
Responsed Disease Melanoma [ICD-11: 2C30]
Target Regulator Methyltransferase-like 3 (METTL3) WRITER
Target Regulation Up regulation
Cell Process Cell invasion/migration
In-vitro Model 451Lu Cutaneous melanoma Homo sapiens CVCL_6357
A-375 Amelanotic melanoma Homo sapiens CVCL_0132
A375-MA2 Amelanotic melanoma Homo sapiens CVCL_X495
MeWo Cutaneous melanoma Homo sapiens CVCL_0445
SK-MEL-2 Melanoma Homo sapiens CVCL_0069
WM164 Cutaneous melanoma Homo sapiens CVCL_7928
WM3211 Acral lentiginous melanoma Homo sapiens CVCL_6797
WM3918 Melanoma Homo sapiens CVCL_C279
WM793 Melanoma Homo sapiens CVCL_8787
References
Ref 1 RNA m6A methyltransferase METTL3 regulates invasiveness of melanoma cells by matrix metallopeptidase 2. Melanoma Res. 2019 Aug;29(4):382-389. doi: 10.1097/CMR.0000000000000580.
Ref 2 CBLL1 is highly expressed in non-small cell lung cancer and promotes cell proliferation and invasion. Thorac Cancer. 2019 Jun;10(6):1479-1488. doi: 10.1111/1759-7714.13097. Epub 2019 May 23.